Similar articles

• Controlled trial of cephradine versus cefuroxime in vascular surgery.

  Barlow IW, Ausobsky JR, Wilkinson D, Kester RC. Barlow IW, et al. Int J Clin Pharmacol Res. 1989;9(3):223-7. Int J Clin Pharmacol Res. 1989. PMID: 2663737 Clinical Trial.
• Cost-benefit analysis of cephradine and mezlocillin prophylaxis for abdominal and vaginal hysterectomy.

  Davey PG, Duncan ID, Edward D, Scott AC. Davey PG, et al. Br J Obstet Gynaecol. 1988 Nov;95(11):1170-7. doi: 10.1111/j.1471-0528.1988.tb06796.x. Br J Obstet Gynaecol. 1988. PMID: 3145014 Clinical Trial.
• The use of cephradine in the prevention of gynecologic surgical infections.

  Stage AH, Brooks GG, Janies JL, Hart TM, McElwee TW Jr, Hardin WK, Muslow GJ. Stage AH, et al. J La State Med Soc. 1979 Jan;131(1):1-4. J La State Med Soc. 1979. PMID: 368267 Clinical Trial. No abstract available.
• Overview of cephalosporin prophylaxis.

  Kaiser AB. Kaiser AB. Am J Surg. 1988 May 31;155(5A):52-5. doi: 10.1016/s0002-9610(88)80213-7. Am J Surg. 1988. PMID: 3287969 Review.
• The role of cephalosporins in surgical prophylaxis.

  Gorbach SL. Gorbach SL. J Antimicrob Chemother. 1989 Apr;23 Suppl D:61-70. doi: 10.1093/jac/23.suppl_d.61. J Antimicrob Chemother. 1989. PMID: 2656627 Review.